Recently, the Ministry of science and Technology issued the decision on Commending the advanced collectives and individuals of the national science and technology system in combating covid-19 pneumonia, and Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) won the title of “advanced collectives of the national science and technology system in combating covid-19 pneumonia”.
This time, 163 advanced collectives and 314 advanced individuals were commended in the national science and technology system, and a total of 5 collectives and 6 individuals in Fujian Province were on the list. Zhangzhou Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) Pharmaceutical Co., Ltd. is one of the five units that won the advanced collective in Fujian Province this time.
As a time-honored pharmaceutical brand with a long history and a well-known state-owned listed enterprise, Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) pharmaceutical industry, while adhering to the quality spirit of the time-honored pharmaceutical brand, actively uses scientific and technological innovation to enable the enterprise’s strategy of “multi-core drive and two-way development”.
On the product side, Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) pharmaceutical adheres to high investment, innovative research and development, makes efforts to master the core patented technology of the industrial chain, strengthens cooperation with many domestic and foreign universities and scientific research institutions, and carries out Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) efficacy and mechanism research by means of evidence-based medicine, molecular biology and other modern scientific and technological means, so as to make the traditional Chinese medicine culture recognized by the world with modern medical technology and achievements.
During the outbreak of covid-19 epidemic in 2020, Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) pharmaceutical industry urgently developed and produced “Qingfei Paidu Decoction” in the shortest time, donated to the front line of “epidemic” and made every effort to ensure epidemic prevention materials such as masks. In September 2021, the covid-19 epidemic broke out in Fujian, and Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) pharmaceutical took the initiative to donate more than 8200 doses of “Qingfei Paidu Decoction” granules to Zhangzhou, Putian, Xiamen and other places to fully support the front-line anti epidemic work.
In recent years, Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) has maintained double-digit growth in revenue and net profit. On January 20, Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) disclosed the performance express of 2021, and the performance reached a new high. The revenue was 8.026 billion yuan, a year-on-year increase of 23.27%; The net profit was 2.433 billion yuan, a year-on-year increase of 45.55%.
As of the closing on February 25, the market value of Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) reached 215.3 billion yuan, 98.6 billion yuan more than Yunnan Baiyao Group Co.Ltd(000538) in the second place, firmly sitting on the throne of “first brother” of traditional Chinese medicine stocks.
